CYT

Analyst Sentiment

Wall St. Consensus
Hold
5 analysts·Limited coverage
50
Score
2 Buy (40%)1 Hold (20%)2 Sell (40%)
Rating Breakdown
Strong Buy
00%
Buy
240%
Hold
120%
Sell
240%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$2.00
-33.8%
Consensus
$2.00
-33.8%
Bull
$2.00
-33.8%
12-Month Target Range5 analysts
$2.00$2.00$2.00
Current $3.02Consensus
Current Price
$3.02
Above Consensus
$1.02

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Feb 3, 2023Morgan Stanley
Morgan Stanley Downgrades Cyteir Therapeutics to Underweight, Lowers Price Target to $2
Target:$2.00
+23.5%from $1.62
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.